JP5701060B2 - 腹部大動脈瘤の治療のためのトリアゾロ［４，５−ｄ］ピリミジン化合物 - Google Patents
腹部大動脈瘤の治療のためのトリアゾロ［４，５−ｄ］ピリミジン化合物 Download PDFInfo
- Publication number
- JP5701060B2 JP5701060B2 JP2010536888A JP2010536888A JP5701060B2 JP 5701060 B2 JP5701060 B2 JP 5701060B2 JP 2010536888 A JP2010536888 A JP 2010536888A JP 2010536888 A JP2010536888 A JP 2010536888A JP 5701060 B2 JP5701060 B2 JP 5701060B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- treatment
- thrombus
- day
- aneurysm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07301616.4 | 2007-12-03 | ||
| EP07301616 | 2007-12-03 | ||
| PCT/SE2008/051386 WO2009072967A1 (en) | 2007-12-03 | 2008-12-02 | Triazolo [4,5-d] pyrimidine compounds for treatment of abdominal aortic aneurysms |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011505417A JP2011505417A (ja) | 2011-02-24 |
| JP2011505417A5 JP2011505417A5 (enExample) | 2012-01-12 |
| JP5701060B2 true JP5701060B2 (ja) | 2015-04-15 |
Family
ID=40717966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010536888A Active JP5701060B2 (ja) | 2007-12-03 | 2008-12-02 | 腹部大動脈瘤の治療のためのトリアゾロ［４，５−ｄ］ピリミジン化合物 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US20100298350A1 (enExample) |
| EP (1) | EP2229172B1 (enExample) |
| JP (1) | JP5701060B2 (enExample) |
| KR (1) | KR101563757B1 (enExample) |
| CN (2) | CN101883565A (enExample) |
| AU (1) | AU2008331984B2 (enExample) |
| BR (1) | BRPI0819458A2 (enExample) |
| CA (1) | CA2707488C (enExample) |
| CY (1) | CY1115760T1 (enExample) |
| DK (1) | DK2229172T3 (enExample) |
| EA (1) | EA201000928A1 (enExample) |
| ES (1) | ES2522317T3 (enExample) |
| HR (1) | HRP20141081T1 (enExample) |
| IL (1) | IL205613A (enExample) |
| MX (1) | MX2010006101A (enExample) |
| MY (1) | MY159656A (enExample) |
| NZ (1) | NZ585513A (enExample) |
| PL (1) | PL2229172T3 (enExample) |
| PT (1) | PT2229172E (enExample) |
| RS (1) | RS53635B1 (enExample) |
| SI (1) | SI2229172T1 (enExample) |
| UA (1) | UA100864C2 (enExample) |
| WO (1) | WO2009072967A1 (enExample) |
| ZA (1) | ZA201003599B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102653539B (zh) * | 2011-03-01 | 2014-09-17 | 秦引林 | 一种抗血小板聚集化合物及其药物组合 |
| CN102924457A (zh) * | 2011-08-12 | 2013-02-13 | 上海恒瑞医药有限公司 | 三唑并嘧啶类衍生物、其制备方法及其用途 |
| EP2750676B1 (en) | 2011-08-30 | 2018-01-10 | University of Utah Research Foundation | Methods and compositions for treating nephrogenic diabetes insipidus |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997003084A1 (en) * | 1995-07-11 | 1997-01-30 | Astra Pharmaceuticals Ltd. | New inhibitors of platelet aggregation |
| AR017014A1 (es) * | 1997-07-22 | 2001-08-22 | Astrazeneca Ab | Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos |
| TWI229674B (en) * | 1998-12-04 | 2005-03-21 | Astra Pharma Prod | Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses |
| GB0013407D0 (en) * | 2000-06-02 | 2000-07-26 | Astrazeneca Ab | Forms of a chemical compound |
| SE0101932D0 (sv) * | 2001-05-31 | 2001-05-31 | Astrazeneca Ab | Pharmaceutical combinations |
| WO2009007675A2 (en) * | 2007-07-11 | 2009-01-15 | Cardoz Ab | Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist |
-
2008
- 2008-02-12 UA UAA201005772A patent/UA100864C2/uk unknown
- 2008-12-02 RS RS20140600A patent/RS53635B1/sr unknown
- 2008-12-02 PT PT88573548T patent/PT2229172E/pt unknown
- 2008-12-02 SI SI200831311T patent/SI2229172T1/sl unknown
- 2008-12-02 HR HRP20141081AT patent/HRP20141081T1/hr unknown
- 2008-12-02 JP JP2010536888A patent/JP5701060B2/ja active Active
- 2008-12-02 CN CN2008801189070A patent/CN101883565A/zh active Pending
- 2008-12-02 CN CN201410139401.5A patent/CN103919781A/zh active Pending
- 2008-12-02 DK DK08857354.8T patent/DK2229172T3/da active
- 2008-12-02 BR BRPI0819458 patent/BRPI0819458A2/pt not_active Application Discontinuation
- 2008-12-02 MY MYPI2010002526A patent/MY159656A/en unknown
- 2008-12-02 EP EP08857354.8A patent/EP2229172B1/en active Active
- 2008-12-02 MX MX2010006101A patent/MX2010006101A/es active IP Right Grant
- 2008-12-02 ES ES08857354.8T patent/ES2522317T3/es active Active
- 2008-12-02 PL PL08857354T patent/PL2229172T3/pl unknown
- 2008-12-02 AU AU2008331984A patent/AU2008331984B2/en active Active
- 2008-12-02 EA EA201000928A patent/EA201000928A1/ru unknown
- 2008-12-02 US US12/745,733 patent/US20100298350A1/en not_active Abandoned
- 2008-12-02 NZ NZ585513A patent/NZ585513A/en unknown
- 2008-12-02 WO PCT/SE2008/051386 patent/WO2009072967A1/en not_active Ceased
- 2008-12-02 CA CA2707488A patent/CA2707488C/en not_active Expired - Fee Related
- 2008-12-02 KR KR1020107013193A patent/KR101563757B1/ko active Active
-
2010
- 2010-05-06 IL IL205613A patent/IL205613A/en active IP Right Grant
- 2010-05-20 ZA ZA2010/03599A patent/ZA201003599B/en unknown
-
2014
- 2014-10-30 CY CY20141100893T patent/CY1115760T1/el unknown
-
2015
- 2015-01-15 US US14/597,255 patent/US20150272955A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL205613A0 (en) | 2010-11-30 |
| ES2522317T3 (es) | 2014-11-14 |
| PT2229172E (pt) | 2014-11-03 |
| SI2229172T1 (sl) | 2014-12-31 |
| WO2009072967A1 (en) | 2009-06-11 |
| EP2229172B1 (en) | 2014-09-10 |
| UA100864C2 (uk) | 2013-02-11 |
| HK1148195A1 (en) | 2011-09-02 |
| KR101563757B1 (ko) | 2015-10-27 |
| CA2707488A1 (en) | 2009-06-11 |
| ZA201003599B (en) | 2012-10-31 |
| NZ585513A (en) | 2012-07-27 |
| AU2008331984A1 (en) | 2009-06-11 |
| CN101883565A (zh) | 2010-11-10 |
| MX2010006101A (es) | 2010-10-04 |
| BRPI0819458A2 (pt) | 2015-05-05 |
| KR20100099175A (ko) | 2010-09-10 |
| HRP20141081T1 (hr) | 2015-01-02 |
| CY1115760T1 (el) | 2017-01-25 |
| PL2229172T3 (pl) | 2015-01-30 |
| DK2229172T3 (da) | 2014-11-10 |
| US20150272955A1 (en) | 2015-10-01 |
| EP2229172A4 (en) | 2012-12-26 |
| AU2008331984B2 (en) | 2012-08-16 |
| CA2707488C (en) | 2015-07-28 |
| EP2229172A1 (en) | 2010-09-22 |
| CN103919781A (zh) | 2014-07-16 |
| MY159656A (en) | 2017-01-13 |
| RS53635B1 (sr) | 2015-04-30 |
| IL205613A (en) | 2015-04-30 |
| EA201000928A1 (ru) | 2010-12-30 |
| JP2011505417A (ja) | 2011-02-24 |
| US20100298350A1 (en) | 2010-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7863356B2 (ja) | 異常な新生血管形成を伴う眼疾患を処置するためにニンテダニブを使用する組成物および方法 | |
| US6083501A (en) | Drug for prevention and therapy of diseases caused by fibrinoid formation or thrombus formation in the lung and model animals of the diseases | |
| Fujisaka et al. | Angiotensin II promotes aortic valve thickening independent of elevated blood pressure in apolipoprotein-E deficient mice | |
| JP2019504064A (ja) | 抗プロ／潜在型ミオスタチン抗体およびその使用方法 | |
| JP2001523214A (ja) | Ｐｄｇｆアンタゴニストおよびヘパリンを使用する内膜過形成を抑制するための組成物 | |
| CN100352442C (zh) | 药物组合 | |
| US20120046333A1 (en) | Methods and Compositions of PI-3 Kinase Inhibitors for Treating Fibrosis | |
| AU2025205402A1 (en) | New oral pharmaceutical composition and dose regimen for the therapy of progressive fibrosing interstitial lung diseases | |
| JP2011505417A (ja) | 腹部大動脈瘤の治療のためのトリアゾロ［４，５−ｄ］ピリミジン化合物 | |
| US20200030298A1 (en) | Compositions and Methods of Treating Muscular Dystrophy with Thromboxane-A2 Receptor Antagonists | |
| ES2548725T3 (es) | Métodos para tratar estados asociados con la acumulación excesiva de matriz celular | |
| JP2007537184A (ja) | 抗血小板剤に対する耐性を治療するためのジピリダモールの使用 | |
| TW202045180A (zh) | 治療纖維化之方法 | |
| Di Vita et al. | Impact of heavy polypropylene mesh and composite light polypropylene and polyglactin 910 on the inflammatory response | |
| TWI344366B (en) | Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients | |
| CZ300888B6 (cs) | Lécivo pro lécení srdecního selhání obsahující antagonistu kortizolu | |
| HK1148195B (en) | Ticagrelor for treatment of abdominal aortic aneurysms | |
| WO2022043381A1 (en) | Anti-fibrotic combination | |
| CN101068548B (zh) | 用于减少、稳定富含脂质的斑块和/或防止富含脂质的斑块破裂的方法 | |
| WO2004017906A2 (en) | Modulation of matrix metalloproteinase (mmp) activity with aldosterone blocker(s) | |
| WO2023230593A1 (en) | Ptp1b inhibitors for treating lung injury | |
| US20130095059A1 (en) | Inhaled no donor kmups derivative preventing allergic pulmonary vascular and bronchial inflammation via suppressed cytokines, inos and inflammatory cell counts in asthma model | |
| WO2024091485A1 (en) | Compositions and methods for treating or preventing pulmonary fibrosis | |
| JP2005298336A (ja) | 炎症性疾患治療用薬剤 | |
| HK1258734B (en) | Compositions and methods of treating muscular dystrophy with thromboxane-a2 receptor antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111114 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20111114 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130702 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131002 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20131009 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131227 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140702 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141104 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20141218 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150126 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150217 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5701060 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |